Ermanno Puxeddu

2.0k total citations
57 papers, 1.3k citations indexed

About

Ermanno Puxeddu is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Ermanno Puxeddu has authored 57 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Pulmonary and Respiratory Medicine, 29 papers in Physiology and 7 papers in Molecular Biology. Recurrent topics in Ermanno Puxeddu's work include Chronic Obstructive Pulmonary Disease (COPD) Research (28 papers), Asthma and respiratory diseases (26 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (13 papers). Ermanno Puxeddu is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (28 papers), Asthma and respiratory diseases (26 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (13 papers). Ermanno Puxeddu collaborates with scholars based in Italy, United States and United Kingdom. Ermanno Puxeddu's co-authors include Paola Rogliani, Mario Cazzola, Luigino Calzetta, Josuel Ora, Maria Gabriella Matera, Francesco Cavalli, Angelo Coppola, Francesco Facciolo, Gabriella Pezzuto and Cesare Saltini and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ermanno Puxeddu

54 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ermanno Puxeddu Italy 20 803 562 141 124 102 57 1.3k
Thérèse Lapperre Denmark 25 1.3k 1.6× 918 1.6× 290 2.1× 217 1.8× 113 1.1× 77 2.1k
Amit Chopra United States 22 617 0.8× 356 0.6× 232 1.6× 155 1.3× 255 2.5× 137 1.7k
Philip W. Ind United Kingdom 23 1.3k 1.7× 1.2k 2.1× 46 0.3× 202 1.6× 49 0.5× 66 2.1k
Bruce A. Hyma United States 11 298 0.4× 415 0.7× 37 0.3× 66 0.5× 25 0.2× 13 966
Scott E. Sinclair United States 22 960 1.2× 149 0.3× 53 0.4× 249 2.0× 58 0.6× 46 1.7k
Daniela Adamo Italy 23 118 0.1× 501 0.9× 160 1.1× 92 0.7× 105 1.0× 83 1.4k
Tai-Fai Fok Hong Kong 20 232 0.3× 199 0.4× 30 0.2× 107 0.9× 116 1.1× 32 975
Bernabé Jurado Gámez Spain 22 364 0.5× 578 1.0× 88 0.6× 281 2.3× 68 0.7× 81 1.3k
Qunming Dong United States 11 1.5k 1.9× 208 0.4× 102 0.7× 234 1.9× 20 0.2× 26 2.1k
L. Hanssens Belgium 18 291 0.4× 249 0.4× 20 0.1× 175 1.4× 44 0.4× 63 1.2k

Countries citing papers authored by Ermanno Puxeddu

Since Specialization
Citations

This map shows the geographic impact of Ermanno Puxeddu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ermanno Puxeddu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ermanno Puxeddu more than expected).

Fields of papers citing papers by Ermanno Puxeddu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ermanno Puxeddu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ermanno Puxeddu. The network helps show where Ermanno Puxeddu may publish in the future.

Co-authorship network of co-authors of Ermanno Puxeddu

This figure shows the co-authorship network connecting the top 25 collaborators of Ermanno Puxeddu. A scholar is included among the top collaborators of Ermanno Puxeddu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ermanno Puxeddu. Ermanno Puxeddu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elia, Stefano, et al.. (2024). Spontaneous Ventilation Thoracoscopic Lung Biopsy in Undetermined Interstitial Lung Disease: Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 13(2). 374–374. 3 indexed citations
2.
Liccardi, Gennaro, Matteo Martini, Maria Beatrice Bilò, et al.. (2024). A narrative review on allergy and exposure to domestic and non-domestic animals: favorable and unfavorable effects. European Annals of Allergy and Clinical Immunology. 57(3). 99–99.
3.
Ora, Josuel, et al.. (2022). Expert guidance on the management and challenges of long-COVID syndrome: a systematic review. Expert Opinion on Pharmacotherapy. 24(3). 315–330. 8 indexed citations
4.
Puxeddu, Ermanno, et al.. (2020). Experimental Glucocorticoid Receptor Agonists for the Treatment of Asthma: A Systematic Review. SHILAP Revista de lepidopterología. 1 indexed citations
5.
Rogliani, Paola, et al.. (2020). <p>Experimental Glucocorticoid Receptor Agonists for the Treatment of Asthma: A Systematic Review</p>. Journal of Experimental Pharmacology. Volume 12. 233–253. 18 indexed citations
6.
Ritondo, Beatrice Ludovica, Ermanno Puxeddu, Luigino Calzetta, Mario Cazzola, & Paola Rogliani. (2020). Efficacy and safety of triple combination therapy for treating chronic obstructive pulmonary disease: an expert review. Expert Opinion on Pharmacotherapy. 22(5). 611–620. 8 indexed citations
7.
Liguori, Claudio, Mariangela Pierantozzi, Matteo Spanetta, et al.. (2020). Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection. Brain Behavior and Immunity. 88. 11–16. 152 indexed citations
8.
Cazzola, Mario, Ermanno Puxeddu, Josuel Ora, & Paola Rogliani. (2019). Evolving Concepts in Chronic Obstructive Pulmonary Disease Blood-Based Biomarkers. Molecular Diagnosis & Therapy. 23(5). 603–614. 15 indexed citations
9.
Rogliani, Paola, Maria Gabriella Matera, Clive Page, et al.. (2019). Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine. Respiratory Research. 20(1). 104–104. 50 indexed citations
10.
Matera, Maria Gabriella, Luigino Calzetta, Ermanno Puxeddu, Paola Rogliani, & Mario Cazzola. (2018). A safety comparison of LABA+LAMA vs LABA+ICS combination therapy for COPD. Expert Opinion on Drug Safety. 17(5). 509–517. 4 indexed citations
11.
Shute, Janis K., Ermanno Puxeddu, & Luigino Calzetta. (2018). Therapeutic use of heparin and derivatives beyond anticoagulation in patients with bronchial asthma or COPD. Current Opinion in Pharmacology. 40. 39–45. 31 indexed citations
12.
Calzetta, Luigino, Paola Rogliani, Josuel Ora, et al.. (2017). LABA/LAMA combination in COPD: a meta-analysis on the duration of treatment. European Respiratory Review. 26(143). 160043–160043. 48 indexed citations
13.
Rogliani, Paola, Josuel Ora, Ermanno Puxeddu, Maria Gabriella Matera, & Mario Cazzola. (2017). Adherence to COPD treatment: Myth and reality. Respiratory Medicine. 129. 117–123. 73 indexed citations
14.
Cazzola, Mario, et al.. (2016). Onset of action of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in patients with COPD. Pulmonary Pharmacology & Therapeutics. 39. 48–53. 7 indexed citations
15.
D’Antonio, Salvatore, et al.. (2016). An unusual outbreak of nontuberculous mycobacteria in hospital respiratory wards: Association with nontuberculous mycobacterial colonization of hospital water supply network. International Journal of Mycobacteriology. 5(2). 244–247. 17 indexed citations
16.
Cazzola, Mario, Luigino Calzetta, Josuel Ora, et al.. (2015). Searching for the synergistic effect between aclidinium and formoterol: From bench to bedside. Respiratory Medicine. 109(10). 1305–1311. 51 indexed citations
17.
Sangiuolo, Federica, Ermanno Puxeddu, Gabriella Pezzuto, et al.. (2014). HFE gene variants and iron-induced oxygen radical generation in idiopathic pulmonary fibrosis. European Respiratory Journal. 45(2). 483–490. 24 indexed citations
18.
Bauleo, Lisa, Angelo Coppola, Gianluigi Sergiacomi, et al.. (2013). Incidence of idiopathic pulmonary fibrosis in Italy. Analysis of hospital admission and mortality databases of a large Italian region. European Respiratory Journal. 42(Suppl 57). P2326–P2326. 2 indexed citations
19.
Cazzola, Mario, Andrea Segreti, Ermanno Puxeddu, et al.. (2012). Effect of an additional dose of indacaterol in COPD patients under regular treatment with indacaterol. Respiratory Medicine. 107(1). 107–111. 9 indexed citations
20.
Cazzola, Mario, Ermanno Puxeddu, Germano Bettoncelli, et al.. (2010). The prevalence of asthma and COPD in Italy: A practice-based study. Respiratory Medicine. 105(3). 386–391. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thérèse Lapperre Breakdown of academic impact, for papers by Amit Chopra Breakdown of academic impact, for papers by Philip W. Ind Breakdown of academic impact, for papers by Bruce A. Hyma Breakdown of academic impact, for papers by Scott E. Sinclair Breakdown of academic impact, for papers by Daniela Adamo Breakdown of academic impact, for papers by Tai-Fai Fok Breakdown of academic impact, for papers by Bernabé Jurado Gámez Breakdown of academic impact, for papers by Qunming Dong Breakdown of academic impact, for papers by L. Hanssens
Rankless by CCL
2026